Research programme: immunecheckpoint inhibitor combination therapy - VCN Biosciences
Latest Information Update: 31 Jan 2017
At a glance
- Originator VCN Biosciences
- Class Gene therapies; Oncolytic viruses
- Mechanism of Action Gene transference
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 24 Jan 2017 Preclinical trials in Cancer in Spain (Parenteral)